HomeCompareSIRO vs EPRT

SIRO vs EPRT: Dividend Comparison 2026

SIRO yields 0.58% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPRT wins by $42.9K in total portfolio value
10 years
SIRO
SIRO
● Live price
0.58%
Share price
$109.97
Annual div
$0.64
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$60.44
Full SIRO calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — SIRO vs EPRT

📍 EPRT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIROEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIRO + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SIRO pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIRO
Annual income on $10K today (after 15% tax)
$49.47/yr
After 10yr DRIP, annual income (after tax)
$51.37/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EPRT beats the other by $10,863.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIRO + EPRT for your $10,000?

SIRO: 50%EPRT: 50%
100% EPRT50/50100% SIRO
Portfolio after 10yr
$41.9K
Annual income
$6,450.58/yr
Blended yield
15.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

SIRO
No analyst data
Altman Z
28.1
Piotroski
7/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIRO buys
0
EPRT buys
0
No recent congressional trades found for SIRO or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIROEPRT
Forward yield0.58%3.92%
Annual dividend / share$0.64$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$20.5K$63.4K
Annual income after 10y$60.44$12,840.73
Total dividends collected$594.00$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SIRO vs EPRT ($10,000, DRIP)

YearSIRO PortfolioSIRO Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$10,758$58.20$11,205$505.18$447.00EPRT
2$11,570$58.51$12,672$682.46$1.1KEPRT
3$12,438$58.81$14,490$930.48$2.1KEPRT
4$13,368$59.09$16,786$1,282.69$3.4KEPRT
5$14,363$59.35$19,753$1,791.56$5.4KEPRT
6$15,428$59.60$23,677$2,541.64$8.2KEPRT
7$16,568$59.83$29,008$3,672.99$12.4KEPRT
8$17,788$60.05$36,463$5,425.08$18.7KEPRT
9$19,094$60.25$47,238$8,221.57$28.1KEPRT
10$20,490$60.44$63,385$12,840.73$42.9KEPRT

SIRO vs EPRT: Complete Analysis 2026

SIROStock

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.

Full SIRO Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this SIRO vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIRO vs SCHDSIRO vs JEPISIRO vs OSIRO vs KOSIRO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.